Salem Radio Network News Tuesday, October 14, 2025

Health

CapVest eyes majority stake in German drugmaker Stada, Bloomberg News reports

Carbonatix Pre-Player Loader

Audio By Carbonatix

(Reuters) -London-based buyout firm CapVest Partners is in talks to acquire a majority stake in German drugmaker Stada Arzneimittel, Bloomberg News reported on Tuesday.

The deal would value Stada Arzneimittel at about 10 billion euros ($11.75 billion) including debt, the report said, citing unnamed sources.

CapVest is in discussions with Stada’s private equity owners, Bain Capital and Cinven, regarding the transaction. Stada has also been exploring a potential listing, the report said.

CapVest and Stada declined to comment.

Stada, known for its cold medicine Grippostad, sunscreen Ladival and the cough syrup Silomat, in March postponed a planned IPO in Frankfurt due to market volatility.

Bankers advising Bain Capital and Cinven recommended against proceeding with the listing at that time, Reuters reported.

($1 = 0.8511 euros)

(Reporting by Angela Christy in Bengaluru; Editing by Tasim Zahid)

Previous
Next
The Media Line News
Salem Media, our partners, and affiliates use cookies and similar technologies to enhance your browsing experience, analyze site traffic, personalize site content, and deliver relevant video recommendations. By using this website and continuing to navigate, you consent to our use of such technologies and the sharing of video viewing activity with third-party partners in accordance with the Video Privacy Protection Act and other privacy laws. Privacy Policy
OK
X CLOSE